Skip to main content
Premium Trial:

Request an Annual Quote

Martha Trela, Trevor Nicholls, Timothy Mayleben, Robert Saltmarsh, Charles Craig, Giovanni Ferrara, Richard Haiduck, James Watson, and more ...

Premium

Martha Trela has joined Affymetrix in a sales and marketing position. She comes to Affymetrix from Applied Biosystems, where she was vice president for worldwide marketing programs and communications.


Trevor Nicholls has become a member of the European business development team of Affymetrix, the company said in an SEC filing last week. He used to be Affymetrix’s executive vice president for product marketing and development.


Timothy Mayleben has joined the board of directors of Rubicon Genomics, replacing Richard Sloan, the Ann Arbor, Mich.-based company said today. Most recently, he was COO and CFO of Esperion Therapeutics, which was recently acquired by Pfizer.


Robert Saltmarsh has been promoted to chief financial officer of Nanogen, the San Diego-based company said last week. He joined Nanogen as vice president of corporate development in September. Most recently, he was a consultant for several startup companies and taught entrepreneurial finance at the University of California at Riverside. Saltmarsh holds a BA in economics and an MBA in finance from the University of Michigan.


Charles Craig has become president of the Georgia Biomedical Partnership, the industry organization said last week. He is the first full-time president of GBP. Previously, Craig was director of publications for the Biotechnology Industry Organization. He holds a Master’s degree in journalism from Louisiana State University and a BA from the University of Virginia.


Burrill & Co. has made a number of staff changes, the merchant bank said last week. Giovanni Ferrara, Richard Haiduck, and James Watson became managing directors; Bryant Fong has become principal; Stephen Kujawa has become director; and David Haselwood and Rizwan Velji have become senior associates. The company appointed Ann Hanham, John Kim, Roger Wyse, Mike Ullman, John Haag, and Tim Young as general partners of the Burrill Life Sciences Capital Fund III.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.